Please carefully review the following terms and conditions of use (“Terms and Conditions”), which apply to everyone who visits this Amneal Pharmaceuticals, Inc. and its subsidiaries (collectively, “Amneal”) website. By accessing and using this website, you are agreeing to abide by, and be bound by, the following Terms and Conditions and any amendments in effect at the time of your visit. Amneal may modify these Terms and Conditions at any time without notice by updating these legal notices, and we encourage you to review the Terms and Conditions because any such modifications will be binding on you.
Trademarks and service marks on this Amneal website, including but not limited to product names, are registered and unregistered trademarks of Amneal and others. The contents of this Amneal website (including, without limitation, the arrangement and layout of the websites; names and logos; and text, illustrations and artwork) are the copyrighted and/or trademarked property of Amneal (or the original creator of the material) and are protected under applicable copyright and trademark laws. Nothing contained on the websites should be construed as granting any license or right to use any such marks or copyrighted material without the written permission of Amneal or such other party who may own such mark(s) or copyrighted material. Any unauthorized use of the trademarks, copyrights or other contents of this Amneal website may violate civil or criminal laws.
The product catalog on the Amneal website has been designed as a quick reference for generic pharmaceuticals and their corresponding brand names. Some products-either brand or generic-may no longer be available on the market due to discontinuations from product portfolios. This product catalog may not represent our complete product portfolio due to additional product launches or product discontinuations. The products displayed on this web site are intended as a reference source only and not for prescribing or dispensing purposes.
Patients should always obtain complete medical information about their prescription medicines (beneficial medical uses and possible adverse effects) from the product’s information leaflet and/or by discussing the appropriate use of any medicine(s) directly with their prescribing physician. Consumers should not construe any information herein as medical advice. Amneal and its affiliates are not responsible for any reliance on or use of any information included herein.
Nothing contained in Amneal’s website should be construed as medical, legal, investment, financial or other advice. Without limitation, nothing contained in the sites should replace medical advice, medical visits or recommendations from health care providers. Patients should always consult with a doctor or other health care provider for medical advice.
Amneal’s website contains links to third-party websites, which are provided as a convenience to users of our site. Amneal makes no claim or warranty of, and is not responsible for, any information found in a linked website. We encourage you to check the disclaimers and other legal notices provided on such linked sites.
No Representation or Warranty
While Amneal uses reasonable efforts to include up-to-date and accurate information on its website, Amneal does not make, and expressly disclaims, any representations or warranties of any kind, either express or implied (including without limitation any implied warranties of merchantability, fitness for a particular purpose or non-infringement) with regard to any such information, its accuracy or completeness or the frequency that it is updated. Everything on Amneal’s website is provided “AS IS”. Amneal assumes no liability or responsibility for any errors or omissions in the content of its websites.
Limitation of Liability
Your use of Amneal’s website is at your own risk. In no event shall Amneal or any of its officers, directors, employees or affiliates, be liable, directly or indirectly, for any damages of any kind or nature, including, without limitation, direct, incidental, punitive or consequential, or any claims or losses, resulting from or in connection with the creation or use of, or reliance on, this site or any information contained herein, any other Amneal website or any linked website contained in any such sites, or any of the information accessed through any such site or from the inability to use any such site. This limitation includes damage to your computer equipment or any viruses that may infect your computer equipment or other property.
These Terms and Conditions of use and your use of this website shall be governed by the laws of the State of New Jersey without regard to conflict of laws principles. Any legal action or proceeding related to the Terms and Conditions or your use of this website shall be brought exclusively in the courts of the State of New Jersey or the United States District Court for the District of New Jersey.
Caution Regarding Forward-Looking Statements
Amneal’s website contains certain statements, regarding matters that are not historical facts and , may be forward-looking statements (as defined in Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the United States Securities Exchange Act of 1934, as amended). We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995 and include this statement for purposes of complying with the safe harbor provisions. Forward-looking statements reflect management’s assumptions, views, plans, objectives and projections about the future and may be identified by the use of words such as “plans,” “expects,” “will,” “anticipates,” “estimates” and other words of similar meaning in conjunction with, among other things: discussions of future operations; expected operating results and financial performance; impact of planned acquisitions and dispositions; our strategy for growth; product development; regulatory approvals; market position and expenditures.
Such forward-looking statements involve risks and uncertainties; consequently, actual results may differ materially from those expressed or implied in the statements. Such risks and uncertainties include, but are not limited to (i) our ability to successfully develop, license, acquire and commercialize new products on a timely basis; (ii) the competition we face in the pharmaceutical industry from brand and generic drug product companies, and the impact of that competition on our ability to set prices,; (iii) our ability to obtain exclusive marketing rights for our products; (iv) our ability to manage our growth through acquisitions and otherwise; (v) our dependence on the sales of a limited number of products for a substantial portion of our total revenues (vi) the continuing trend of consolidation of certain customer groups; (vii) our dependence on third-party suppliers and distributors for raw materials for our products and certain finished goods; (viii) legal, regulatory and legislative efforts by our brand competitors to deter competition from our generic alternatives; (ix) the impact of severe weather; (x) the impact of the ongoing COVID-19 pandemic; (xi) risks related to federal regulation of arrangements between manufacturers of branded and generic products; (xii) our reliance on certain licenses to proprietary technologies from time to time; (xiii) the significant amount of resources we expend on research and development; (xiv) the risk of product liability and other claims against us by consumers and other third parties; (xv) risks related to changes in the regulatory environment, including U.S. federal and state laws related to healthcare fraud abuse and health information privacy and security and changes in such laws; (xvi) changes to Food and Drug Administration (“FDA”) product approval requirements; (xvii) the impact of healthcare reform and changes in coverage and reimbursement levels by governmental authorities and other third-party payers; (xiii) our dependence on third-party agreements for a portion of our product offerings; (xiv) the impact of global economic conditions; (xx) our ability to identify, make and integrate acquisitions or investments in complementary businesses and products on advantageous terms; (xxi) our substantial amount of indebtedness and our ability to generate sufficient cash to service our indebtedness in the future, and the impact of interest rate fluctuations on such indebtedness; (xxii) our obligations under a tax receivable agreement may be significant; (xxiii) the high concentration of ownership of our Class A Common Stock and the fact that we are controlled by the Amneal Group; and (xxiv) such other factors as may be set forth in the Company’s public filings with the Securities and Exchange Commission.
Forward-looking statements included herein speak only as of the date hereof and we undertake no obligation to revise or update such statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events or circumstances.